Spit test could catch lung cancer early
NCT ID NCT07168993
Summary
This study is testing a new, non-invasive test called FlowPath Lung that analyzes a person's sputum (mucus coughed up from the lungs) to see if it can accurately detect early-stage lung cancer. It is for people at high risk for lung cancer who already have a small lung nodule found on a CT scan. The goal is to see if this simple test can help doctors figure out which nodules are cancerous without more invasive procedures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Audie Murphy VA Medical Center
RECRUITINGSan Antonio, Texas, 78234, United States
-
Brooke Army Medical Center
RECRUITINGSan Antonio, Texas, 78234, United States
-
Clinical Research Associates of Central Pennsylvania
RECRUITINGDuBois, Pennsylvania, 15801, United States
Conditions
Explore the condition pages connected to this study.